Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000934729-13-000013
Filing Date
2013-01-10
Accepted
2013-01-10 15:31:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 tekmira12-12.txt SC 13G 11747
  Complete submission text file 0000934729-13-000013.txt   13660
Mailing Address 111 WEST MONROE ST FLOOR 21E CHICAGO IL 60603
Business Address 111 WEST MONROE STREET P O BOX 755 CHICAGO IL 60690 3124615592
BMO FINANCIAL CORP (Filed by) CIK: 0000934729 (see all company filings)

EIN.: 510275712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 0000

Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
TEKMIRA PHARMACEUTICALS Corp (Subject) CIK: 0001447028 (see all company filings)

EIN.: 980597776 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-85963 | Film No.: 13522813
SIC: 2834 Pharmaceutical Preparations